• OPEN AN ACCOUNT
Indian Indices
Sensex
78,094.64 166.49
( 0.21%)
Global Indices
Nasdaq
52,497.89 268.83
(0.51%)
Dow Jones
7,510.69 52.06
(0.70%)
Hang Seng
64,316.33 2,448.90
(3.96%)
Nikkei 225
10,879.26 -18.01
(-0.17%)
Forex
USD-INR
95.59 -0.10
(-0.11%)
EUR-INR
109.79 0.65
(0.59%)
GBP-INR
128.11 0.75
(0.59%)
JPY-INR
0.59 0.01
(1.09%)

EQUITY - MARKET SCREENER

Vaishali Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
535000
INE972X01022
5.2875441
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VAISHALI
23.71
95.89
EPS(TTM)
Face Value()
Div & Yield %
0.31
2
0
 

Gamco reports consolidated net loss of Rs 48.88 crore in the March 2026 quarter
May 22,2026
Net Loss of Gamco reported to Rs 48.88 crore in the quarter ended March 2026 as against net loss of Rs 17.93 crore during the previous quarter ended March 2025. Sales reported to Rs 73.27 crore in the quarter ended March 2026 as against Rs -3.41 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 47.17 crore in the year ended March 2026 as against net profit of Rs 6.41 crore during the previous year ended March 2025. Sales rose 390.03% to Rs 301.42 crore in the year ended March 2026 as against Rs 61.51 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales73.27-3.41 LP 301.4261.51 390
OPM %-58.20628.45 --9.5823.88 -
PBDT-48.32-23.17 -109 -43.958.20 PL
PBT-48.55-23.35 -108 -44.697.85 PL
NP-48.88-17.93 -173 -47.176.41 PL